Literature DB >> 21467905

Head and neck malignant melanoma: local recurrence rate following wide local excision and immediate reconstruction.

Stephen R Sullivan1, Daniel Z Liu, David W Mathes, F Frank Isik.   

Abstract

Excision of head and neck melanoma is often limited by critical structures, which can lead to incomplete excision with positive pathologic margin and increased local recurrence rate. Complete excision with recommended margins and immediate reconstruction is possible when surgical oncologists and plastic surgeons work collaboratively. Our purpose was to evaluate local recurrence rate after excision and immediate reconstruction. We reviewed 98 consecutive patients treated for primary head and neck cutaneous melanoma at a single institution between 1999 and 2004. We assessed local recurrence rate. A total of 72 patients (73%) were followed for an average of 5.2 ± 1.7 years while 26 patients were excluded due to less than 1 year of follow-up. Adjacent tissue transfer was the most common reconstruction (87%). Local recurrence was reported in 2.8% and distant metastasis in 12.5% of patients. Immediate reconstruction after excision of head and neck melanoma can be safely performed with low local recurrence rate.

Entities:  

Mesh:

Year:  2012        PMID: 21467905     DOI: 10.1097/SAP.0b013e318212683a

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  2 in total

1.  Recurrence Rates Over 20 Years in the Treatment of Malignant Melanoma: Immediate Versus Delayed Reconstruction.

Authors:  Pieter G L Koolen; Tiago R Matos; Ahmed M S Ibrahim; Jie Sun; Bernard T Lee; Robert A Frankenthaler; Samuel J Lin
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-07-12

2.  Impact of Immediate Surgical Reconstruction Following Wide Local Excision of Malignant Head and Neck Melanoma.

Authors:  Allison C Hu; Seung Ah Lee; Emily G Clark; Maki Yamamoto; James G Jakowatz; Gregory R D Evans
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-02-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.